List of Tables
Table 1. Central Nervous System Drugs Market Trends
Table 2. Central Nervous System Drugs Market Drivers & Opportunity
Table 3. Central Nervous System Drugs Market Challenges
Table 4. Central Nervous System Drugs Market Restraints
Table 5. Global Central Nervous System Drugs Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Central Nervous System Drugs Revenue Market Share by Company (2019-2024)
Table 7. Global Central Nervous System Drugs Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Central Nervous System Drugs Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Central Nervous System Drugs Price by Company (2019-2024) & (USD/Unit)
Table 10. Key Manufacturers Central Nervous System Drugs Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Central Nervous System Drugs Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Central Nervous System Drugs
Table 13. Global Central Nervous System Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Central Nervous System Drugs as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Central Nervous System Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Central Nervous System Drugs Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Central Nervous System Drugs Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Central Nervous System Drugs Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Central Nervous System Drugs Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Central Nervous System Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Central Nervous System Drugs Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Central Nervous System Drugs Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Central Nervous System Drugs Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Central Nervous System Drugs Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Central Nervous System Drugs Price by Type (2019-2024) & (USD/Unit)
Table 27. Global Central Nervous System Drugs Price by Type (2025-2030) & (USD/Unit)
Table 28. Global Central Nervous System Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Central Nervous System Drugs Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Central Nervous System Drugs Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Central Nervous System Drugs Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Central Nervous System Drugs Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Central Nervous System Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Central Nervous System Drugs Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Central Nervous System Drugs Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Central Nervous System Drugs Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Central Nervous System Drugs Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Central Nervous System Drugs Price by Application (2019-2024) & (USD/Unit)
Table 39. Global Central Nervous System Drugs Price by Application (2025-2030) & (USD/Unit)
Table 40. Global Central Nervous System Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Central Nervous System Drugs Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Central Nervous System Drugs Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Central Nervous System Drugs Sales Value by Region (2019-2024) & (%)
Table 44. Global Central Nervous System Drugs Sales Value by Region (2025-2030) & (%)
Table 45. Global Central Nervous System Drugs Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Central Nervous System Drugs Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Central Nervous System Drugs Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Central Nervous System Drugs Sales Volume by Region (2019-2024) & (%)
Table 49. Global Central Nervous System Drugs Sales Volume by Region (2025-2030) & (%)
Table 50. Global Central Nervous System Drugs Average Price by Region (2019-2024) & (USD/Unit)
Table 51. Global Central Nervous System Drugs Average Price by Region (2025-2030) & (USD/Unit)
Table 52. Key Countries/Regions Central Nervous System Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Central Nervous System Drugs Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Central Nervous System Drugs Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Central Nervous System Drugs Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Central Nervous System Drugs Sales Volume, (2025-2030) & (K Units)
Table 57. Biogen Company Information
Table 58. Biogen Introduction and Business Overview
Table 59. Biogen Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Biogen Central Nervous System Drugs Product Offerings
Table 61. Biogen Recent Development
Table 62. Pfizer Company Information
Table 63. Pfizer Introduction and Business Overview
Table 64. Pfizer Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 65. Pfizer Central Nervous System Drugs Product Offerings
Table 66. Pfizer Recent Development
Table 67. Teva Company Information
Table 68. Teva Introduction and Business Overview
Table 69. Teva Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 70. Teva Central Nervous System Drugs Product Offerings
Table 71. Teva Recent Development
Table 72. Novartis Company Information
Table 73. Novartis Introduction and Business Overview
Table 74. Novartis Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 75. Novartis Central Nervous System Drugs Product Offerings
Table 76. Novartis Recent Development
Table 77. Johnson & Johnson Company Information
Table 78. Johnson & Johnson Introduction and Business Overview
Table 79. Johnson & Johnson Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 80. Johnson & Johnson Central Nervous System Drugs Product Offerings
Table 81. Johnson & Johnson Recent Development
Table 82. EliLilly Company Information
Table 83. EliLilly Introduction and Business Overview
Table 84. EliLilly Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 85. EliLilly Central Nervous System Drugs Product Offerings
Table 86. EliLilly Recent Development
Table 87. Otsuka Company Information
Table 88. Otsuka Introduction and Business Overview
Table 89. Otsuka Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 90. Otsuka Central Nervous System Drugs Product Offerings
Table 91. Otsuka Recent Development
Table 92. Merck Company Information
Table 93. Merck Introduction and Business Overview
Table 94. Merck Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 95. Merck Central Nervous System Drugs Product Offerings
Table 96. Merck Recent Development
Table 97. AstraZeneca Company Information
Table 98. AstraZeneca Introduction and Business Overview
Table 99. AstraZeneca Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 100. AstraZeneca Central Nervous System Drugs Product Offerings
Table 101. AstraZeneca Recent Development
Table 102. Novartis Company Information
Table 103. Novartis Introduction and Business Overview
Table 104. Novartis Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 105. Novartis Central Nervous System Drugs Product Offerings
Table 106. Novartis Recent Development
Table 107. Takeda Company Information
Table 108. Takeda Introduction and Business Overview
Table 109. Takeda Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 110. Takeda Central Nervous System Drugs Product Offerings
Table 111. Takeda Recent Development
Table 112. Key Raw Materials Lists
Table 113. Raw Materials Key Suppliers Lists
Table 114. Central Nervous System Drugs Downstream Customers
Table 115. Central Nervous System Drugs Distributors List
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Central Nervous System Drugs Product Picture
Figure 2. Global Central Nervous System Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Central Nervous System Drugs Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Central Nervous System Drugs Sales Volume (2019-2030) & (K Units)
Figure 5. Global Central Nervous System Drugs Sales Price (2019-2030) & (USD/Unit)
Figure 6. Central Nervous System Drugs Report Years Considered
Figure 7. Global Central Nervous System Drugs Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Central Nervous System Drugs Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Central Nervous System Drugs Revenue in 2023
Figure 10. Central Nervous System Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. OTC Picture
Figure 12. Rx Drugs Picture
Figure 13. Global Central Nervous System Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Central Nervous System Drugs Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Central Nervous System Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 16. Global Central Nervous System Drugs Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Central Nervous System Drugs Price by Type (2019-2030) & (USD/Unit)
Figure 18. Product Picture of Hospital
Figure 19. Product Picture of Retail Pharmacy
Figure 20. Global Central Nervous System Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global Central Nervous System Drugs Sales Value Market Share by Application, 2023 & 2030
Figure 22. Global Central Nervous System Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 23. Global Central Nervous System Drugs Sales Volume Market Share by Application, 2023 & 2030
Figure 24. Global Central Nervous System Drugs Price by Application (2019-2030) & (USD/Unit)
Figure 25. North America Central Nervous System Drugs Sales Value (2019-2030) & (US$ Million)
Figure 26. North America Central Nervous System Drugs Sales Value by Country (%), 2023 VS 2030
Figure 27. Europe Central Nervous System Drugs Sales Value (2019-2030) & (US$ Million)
Figure 28. Europe Central Nervous System Drugs Sales Value by Country (%), 2023 VS 2030
Figure 29. Asia Pacific Central Nervous System Drugs Sales Value (2019-2030) & (US$ Million)
Figure 30. Asia Pacific Central Nervous System Drugs Sales Value by Country (%), 2023 VS 2030
Figure 31. South America Central Nervous System Drugs Sales Value (2019-2030) & (US$ Million)
Figure 32. South America Central Nervous System Drugs Sales Value by Country (%), 2023 VS 2030
Figure 33. Middle East & Africa Central Nervous System Drugs Sales Value (2019-2030) & (US$ Million)
Figure 34. Middle East & Africa Central Nervous System Drugs Sales Value by Country (%), 2023 VS 2030
Figure 35. Key Countries/Regions Central Nervous System Drugs Sales Value (%), (2019-2030)
Figure 36. Key Countries/Regions Central Nervous System Drugs Sales Volume (%), (2019-2030)
Figure 37. United States Central Nervous System Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 38. United States Central Nervous System Drugs Sales Value by Type (%), 2023 VS 2030
Figure 39. United States Central Nervous System Drugs Sales Value by Application (%), 2023 VS 2030
Figure 40. Europe Central Nervous System Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 41. Europe Central Nervous System Drugs Sales Value by Type (%), 2023 VS 2030
Figure 42. Europe Central Nervous System Drugs Sales Value by Application (%), 2023 VS 2030
Figure 43. China Central Nervous System Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 44. China Central Nervous System Drugs Sales Value by Type (%), 2023 VS 2030
Figure 45. China Central Nervous System Drugs Sales Value by Application (%), 2023 VS 2030
Figure 46. Japan Central Nervous System Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 47. Japan Central Nervous System Drugs Sales Value by Type (%), 2023 VS 2030
Figure 48. Japan Central Nervous System Drugs Sales Value by Application (%), 2023 VS 2030
Figure 49. South Korea Central Nervous System Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 50. South Korea Central Nervous System Drugs Sales Value by Type (%), 2023 VS 2030
Figure 51. South Korea Central Nervous System Drugs Sales Value by Application (%), 2023 VS 2030
Figure 52. Southeast Asia Central Nervous System Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 53. Southeast Asia Central Nervous System Drugs Sales Value by Type (%), 2023 VS 2030
Figure 54. Southeast Asia Central Nervous System Drugs Sales Value by Application (%), 2023 VS 2030
Figure 55. India Central Nervous System Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 56. India Central Nervous System Drugs Sales Value by Type (%), 2023 VS 2030
Figure 57. India Central Nervous System Drugs Sales Value by Application (%), 2023 VS 2030
Figure 58. Central Nervous System Drugs Industrial Chain
Figure 59. Central Nervous System Drugs Manufacturing Cost Structure
Figure 60. Channels of Distribution (Direct Sales, and Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
